<DOC>
	<DOCNO>NCT03085147</DOCNO>
	<brief_summary>The purpose study test investigational dye , call PARPi-FL , use detect type cancer . This first time PARPi-FL tried people . First , investigator test safety PARPi-FL different dos find effect , , people . The investigator also see amount PARPi-FL best suit detect cancer mouth tongue .</brief_summary>
	<brief_title>A Dye Detection Cancer Tongue Mouth</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Olaparib</mesh_term>
	<criteria>Patient â‰¥ 18 year old Newly diagnose histologically cytologically proven squamous cell carcinoma oral cavity pharynx ( OSCC ) Scheduled undergo surgery MSK Tumor stage T1T2 , N , M0 ECOG performance status 0 1 Prior treatment OSCC ( surgery , radiotherapy , chemotherapy ) Field cancerization ( i.e . 2 lesion , multiple precancerous lesion `` unstable appear oral mucosa '' clinical examination ) Active inflammation oral cavity oropharynx Any surgical therapy area oral cavity pharynx within last 2 week Prior ongoing treatment PARP1 inhibitor Known hypersensitivity Olaparib Known Sorbitol hypersensitivity/intolerance Known hypersensitivity PEG300 Eligibility criterion assess experienced oral surgeon , typically CoPI study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Tongue</keyword>
	<keyword>Mouth</keyword>
	<keyword>Fluorescent PARP1 Binding Imaging Agent</keyword>
	<keyword>PARPi-FL</keyword>
	<keyword>15-336</keyword>
</DOC>